What Medication-Assisted Treatment Actually Is
Medication-assisted treatment, or MAT, combines FDA-approved medications with counseling and behavioral therapies to treat substance use disorders. It is not swapping one drug for another. It is a clinically grounded approach that targets both the physical side of dependence and the psychological cravings that make recovery hard to hold onto without proper support.
Here is the thing that a lot of people do not realize. When someone has been using opioids or alcohol for a long time, the brain chemistry actually shifts, and those changes create withdrawal symptoms, intense cravings, and a disrupted neurological baseline that just willpower alone cannot fix. MAT works by targeting opioid receptors or reducing the reinforcing effects of alcohol, so patients feel stable enough to actually show up for counseling and start building habits that last.
And the research backs this up, you know. People who go through expert outpatient rehab services that include MAT alongside counseling tend to stay in treatment longer, experience fewer opioid overdoses, and have stronger long-term outcomes compared to those who only receive counseling. That is not a small difference. That is a meaningful one.
SAMHSA, the National Institute on Drug Abuse, and addiction medicine specialists all recognize MAT as a first-line treatment for opioid dependence and alcohol use disorder. So this is not a fringe approach or a last resort. It is kind of just the standard of good care.
Who MAT Is Designed For
MAT is appropriate for adults dealing with opioid use disorder, alcohol use disorder, or both. That includes people dependent on heroin, prescription pain relievers, fentanyl, or other opioids, as well as people whose alcohol use has progressed to a point where stopping without medical support carries serious physical risk.
It is also appropriate for people who have tried to stop using independently and found that withdrawal symptoms or cravings pulled them back before they could establish stable footing. Many patients who come to us have made genuine attempts to stop on their own. The difficulty they experienced was not a failure of character. It reflects the way prolonged substance use alters brain chemistry in ways that medication can directly address.
MAT is available to adults at all stages of opioid or alcohol dependence, including people currently in crisis, people stepping down from inpatient care, and people who have been managing dependence for years without formal treatment.
Common Situations Where MAT Becomes Necessary
People seek medication-assisted treatment from a range of starting points. Some arrive after a near-fatal opioid overdose. Others come following a DWI charge or a referral from an employer, a hospital discharge planner, or a court.
Some have been managing opioid dependence with street sources and want a safer, medically supervised alternative. Others have completed a residential stay and need continued medication support as part of a structured step-down plan.
Professionals, including nurses, attorneys, and teachers, sometimes seek MAT through specialized programming when their credentials are at risk due to substance use. Working adults who cannot take extended time away from their jobs need treatment that fits around their schedule. Parents, people with caregiving responsibilities, and individuals without financial resources for inpatient care all benefit from MAT delivered in an outpatient setting.
The common thread across all of these situations is that the person needs more than talk therapy alone. They need a clinical foundation that stabilizes the physical aspects of their disorder so the behavioral work can actually take hold.
The Three FDA-Approved Medications Used in MAT
Three FDA-approved medications form the core of MAT for opioid use disorder and alcohol use disorder.
Methadone is a long-acting opioid agonist that prevents withdrawal symptoms and reduces opioid cravings without producing the euphoric effects associated with drug abuse. It is dispensed through licensed opioid treatment programs and requires daily visits during the early stages of treatment. Methadone maintenance has decades of clinical evidence supporting its effectiveness for opioid dependence.
Buprenorphine, available as Suboxone or Subutex, is a partial opioid agonist that reduces cravings and withdrawal symptoms while carrying a lower risk of misuse than full agonists. Clinicians who are certified to prescribe buprenorphine can initiate treatment during an office visit. In qualifying cases, same-day induction is possible, which means a person can begin treatment the same day they are assessed.
Naltrexone, available as an extended-release injectable under the brand name Vivitrol, blocks opioid receptors entirely, preventing opioids from producing any euphoric effects. It is also used to reduce cravings in alcohol use disorder. Unlike methadone and buprenorphine, naltrexone is not itself an opioid, which makes it an option for patients who prefer a non-opioid approach after completing withdrawal.
How the MAT Process Works
The process begins with a clinical assessment. A licensed clinician reviews the patient's substance use history, physical health, mental health, and current living situation. This assessment determines which medication is appropriate, what level of care is needed, and whether any co-occurring mental health conditions require treatment alongside MAT.
Once medication is initiated, patients attend regular appointments for medication management alongside counseling sessions that address the behavioral and psychological dimensions of their disorder. For patients who need a higher level of care than outpatient MAT can provide, our clinics connect directly to the inpatient rehabilitation and adult detoxification programs at our 225-bed Glenville campus. Patients transfer within the same organization with no restart of intake and no break in the clinical relationship.
For adults in the Capital Region specifically, our dual diagnosis outpatient treatment in Troy, NY, integrates MAT with co-occurring mental health care, DWI services, and specialized programming for professionals.
Addressing a Common Misconception About MAT
A common misconception about medication-assisted treatment is that it simply substitutes one form of dependence for another. This framing misunderstands both addiction and how these medications work.
Opioid use disorder is a medical condition involving measurable changes to brain chemistry and opioid receptors. Medications used in MAT correct chemical imbalances and reduce the neurological drivers of craving and relapse. When a patient on methadone maintenance or buprenorphine feels stable, that stability is the goal of treatment, not evidence that treatment is incomplete.
Healthcare practitioners who specialize in addiction medicine, along with federal agencies including SAMHSA and the FDA, are clear on this point. MAT is a medically legitimate treatment for a medical condition. Our clinical team approaches MAT without judgment and addresses these concerns directly during the assessment process.
Related Services That Support MAT
Medication alone does not produce lasting recovery. Our MAT program is integrated with individual counseling, group therapy, and behavioral therapies, including Cognitive Behavioral Therapy and Motivational Interviewing. Patients managing both a substance use disorder and a mental health condition have access to co-occurring disorder treatment that addresses both conditions simultaneously rather than treating them in isolation.
Information about our full addiction treatment program, including how MAT fits within the broader continuum of care, is available through our addiction treatment program page. Details about our organization, our history, and our clinical approach are available at coniferpark.com.
Why Patients Choose Conifer Park for MAT
Conifer Park has operated in New York State since 1983. We are accredited by The Joint Commission, licensed by NYS OASAS, and employee-owned through an ESOP structure, meaning the clinical staff providing care have a direct ownership stake in the organization. We are members of ATLAS and ATPA and participate in New York State's Combat Heroin initiative. That institutional foundation supports the kind of long-term stability that patients in MAT programs need from a treatment provider.
We accept Medicare, Medicaid, most private insurance plans, and self-pay. Named carriers include Healthfirst, Excellus BlueCross BlueShield, Fidelis Care, MetroPlus Health, and MVP Healthcare. Call us at (800) 926-6433 to verify your coverage before your first appointment.
Frequently Asked Questions
Is MAT available on the same day I call?
Same-day MAT is available on a case-by-case basis for patients with opioid dependence who meet clinical criteria. Assessments can typically be scheduled within 24 hours. Walk-ins are welcome.
Does MAT require daily clinic visits?
It depends on the medication. Methadone maintenance typically requires daily visits during early treatment. Buprenorphine and naltrexone appointments are less frequent. Your clinical team will outline your specific schedule after the assessment.
How long does MAT last?
Duration is determined by clinical need, not a fixed timeline. Some patients remain on medication for months, others for years. The clinical team adjusts the plan based on ongoing progress and stability.
Does Conifer Park accept Medicaid for MAT?
Yes. Medicaid is accepted at our clinics. Call (800) 926-6433 to confirm your specific plan before your first appointment.
